Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05343507
PHASE2/PHASE3

Ketamine to Treat Patients With Post-comatose Disorders of Consciousness

Sponsor: University of Liege

View on ClinicalTrials.gov

Summary

The investigators will run a Randomized Clinical Trial with 30 patients with disorders of consciousness (DoC), with intravenous subanesthetic doses of ketamine. Patients will simultaneously undergo TMS-EEG. The piloting will be done on 3 patients, with EEG only.

Official title: Complexity-enhancing Drugs to Treat Disorders of Consciousness (DoC): a Ketamine Study

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2022-05-01

Completion Date

2026-05-01

Last Updated

2022-11-07

Healthy Volunteers

No

Interventions

DRUG

Ketalar 50 MG/ML Injectable Solution

Intravenous solution (other info already provided)

DRUG

Placebo

Saline Solution

Locations (1)

Centre Hospitalier Neurologique William Lennox

Ottignies-Louvain-la-Neuve, Wallonia, Belgium